Adult ADHD Medication Management
For adults with ADHD, start with methylphenidate or lisdexamfetamine as first-line treatment, titrating weekly based on response, with target doses around 1 mg/kg/day for methylphenidate or 0.5 mg/kg for amphetamines. 1, 2
First-Line Medication Options
Stimulants are the recommended first-line pharmacological treatment 1, 2, 3:
Methylphenidate Formulations
- 12-hour formulations: Provide full-day coverage with once-daily dosing
- 8-hour formulations: Intermediate duration
- Immediate-release: 3-4 hours duration for flexible dosing
- Target dose: Approximately 1 mg/kg/day 4, 5
- Patients can typically substitute between brands with equivalent release profiles without problems 2
Lisdexamfetamine
- Duration: Approximately 12 hours with slow onset 2
- Advantage: Minimal abuse potential compared to dexamfetamine due to prodrug formulation 2
- Target dose: Around 0.5 mg/kg for amphetamine-class medications 5
Titration Strategy
Titrate week by week according to response 1. The choice between methylphenidate and lisdexamfetamine should be tailored to:
- Intended duration of action needed
- Patient's daily schedule and symptom pattern
- Individual response and tolerability
Second-Line Options
When stimulants are contraindicated, not tolerated, or ineffective 2, 3:
Atomoxetine
- Dose: 80-100 mg/day 4
- Indication: Particularly useful in adults with concurrent anxiety/depression or those unable to take stimulants 3
Other Alternatives
Critical Dosing Limits
Do not exceed 1 mg/kg for methylphenidate or 0.5 mg/kg for dexamfetamine without careful documentation 5. Higher doses show no empirical evidence of greater improvement and increase risk of serious adverse effects 5. Any dose escalation beyond these limits requires:
- Objective documentation of benefits
- Careful monitoring for adverse consequences
- Consideration of blood level monitoring for compliance or pharmacokinetic issues 5
Monitoring Parameters
Cardiovascular Monitoring
- Blood pressure and heart rate: ADHD medications may increase both parameters 6
- Monitor at baseline and regularly during treatment
Substance Misuse Prevention
Given stimulant diversion and misuse potential 3:
- Employ controlled substance agreements
- Utilize prescription drug monitoring programs
- Regular assessment of medication use patterns
Treatment Response
- Weekly assessment during titration 1
- Evaluate symptom improvement and functional outcomes
- Monitor for adverse effects at each visit
Adjunctive Treatment
Combine pharmacotherapy with psychoeducation and environmental modifications 1. Cognitive-behavioral therapy may improve treatment response when added to medication 4, 6, with evidence showing effectiveness in both short and long term 4.
Common Pitfalls
- Underdosing: Adults require similar mg/kg doses as children for equivalent response 6
- Premature dose escalation: Titrate weekly, not daily, to assess true response 1
- Ignoring comorbidity: Very common in adult ADHD and may require treatment modification 1, 3
- Inadequate monitoring: Cardiovascular parameters and substance misuse risk require ongoing surveillance 6, 3